Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

3.775 +0.425 (+12.69%)
Streaming Delayed Price Updated: 12:56 PM EDT, May 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Clover Health (NASDAQ:CLOV) Misses Q1 Sales Targets
Health insurance company Clover Health (NASDAQ:CLOV) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 33.3% year on year to $462.3 million. Its GAAP loss of $0 per share was... 
Via StockStory
Earnings Scheduled For May 6, 2025
Via Benzinga
Clover Health (CLOV) Q1 Earnings: What To Expect
Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow after market hours. Here’s what to look for. 
Via StockStory
3 Cash-Heavy Stocks Skating on Thin Ice
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Topics Supply Chain
Exposures Supply Chain
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Earnings Scheduled For February 27, 2025
Via Benzinga
(CLOV) - Analyzing Clover Health Investments's Short Interest
Via Benzinga
How Is The Market Feeling About Clover Health Investments?
Via Benzinga
3 Reasons CLOV is Risky and 1 Stock to Buy Instead
Even during a down period for the markets, Clover Health has gone against the grain, climbing to $3.82. Its shares have yielded a 26.1% return over the last six months, beating the S&P 500 by 27.7%.... 
Via StockStory
Topics Stocks
Exposures US Equities
Q4 Earnings Outperformers: Clover Health (NASDAQ:CLOV) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
Unpacking Q4 Earnings: Centene (NYSE:CNC) In The Context Of Other Health Insurance Providers Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Centene (NYSE:CNC) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
Looking Into Clover Health Investments's Recent Short Interest
Via Benzinga
Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
MarketBeat Week in Review – 03/03 - 03/07
Stocks had another down week despite a mostly benign jobs report; and with the latest reads on inflation coming next week the uncertainty may continue 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Missed the Hims & Hers Rally? Clover Health Could Be Next
After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space. 
Via MarketBeat
Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday?
Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA) 
Via Benzinga
Clover Health (NASDAQ:CLOV) Reports Sales Below Analyst Estimates In Q4 Earnings
Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was... 
Via StockStory
Trump's Tariffs, Potential 'Stagflation': What's Driving Markets Thursday?
The S&P 500 and Nasdaq both slipped into the red, reversing early gains on Thursday, while the Dow Jones remained in positive territory in midday trading. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
What To Expect From Clover Health’s (CLOV) Q4 Earnings
Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc.
Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in. 
Via Benzinga
Topics Stocks
Exposures US Equities
Ten Young Ones
Here are a variety of lesser-known charts from my “Recents” watch list. Quite a few of them look like good bullish plays. 
Via Talk Markets
Topics Stocks / Equities
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:CLOV) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence Fraud
Exposures Artificial Intelligence Legal
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
From FN Media Group LLC
Via GlobeNewswire
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says. 
Via Benzinga
Why Clover Health (CLOV) Stock Is Rising
Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025. 
Via Benzinga
Nvidia, Palantir, Clover Health, Joby Aviation, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. indices closed Wednesday in positive territory, with the Dow Jones Industrial Average increasing by 0.09% to 42,196.52. 
Via Benzinga
Topics Stocks
Exposures US Equities
Clover Health Stock Surges Over 29% On High Volume: Recap
Clover Health Investments shares are trading higher Wednesday amid increased trading volume and gaining traction across social media platforms. Here's what you need to know. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.